CHOLESTOSOMES - Trademark Details
Status: 733 - Fourth Extension - Granted
Image for trademark with serial number 88141769
Serial Number
88141769
Word Mark
CHOLESTOSOMES
Status
733 - Fourth Extension - Granted
Status Date
2021-11-04
Filing Date
2018-10-03
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-09-10
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
DUBOIS, SUSAN L
Statements
Goods and Services
Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of lipids, containing and facilitating the delivery of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis; vaccines and vaccinations to prevent or treat infectious diseases and cancer; drug delivery agents in the form of capsules made of cholesteryl ester, containing and facilitating the delivery of pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung disease, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non- alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), and ankylosing spondylitis; and vaccines and vaccinations to prevent or treat infectious diseases and cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-10-12
Primary Code
005
Current Trademark Owners
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
R. Neil Sudol
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-10-06NEW APPLICATION ENTERED IN TRAM
2018-10-12NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-01-15ASSIGNED TO EXAMINER
2019-01-22NON-FINAL ACTION WRITTEN
2019-01-22NON-FINAL ACTION E-MAILED
2019-01-22NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-07-18TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-07-23ASSIGNED TO LIE
2019-07-29CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-07-29TEAS/EMAIL CORRESPONDENCE ENTERED
2019-08-04APPROVED FOR PUB - PRINCIPAL REGISTER
2019-08-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-09-10PUBLISHED FOR OPPOSITION
2019-09-10OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-11-05NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-04-17TEAS EXTENSION RECEIVED
2020-04-17EXTENSION 1 FILED
2020-04-17EXTENSION 1 GRANTED
2020-04-21NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-05-01ASSIGNED TO EXAMINER
2020-10-29TEAS EXTENSION RECEIVED
2020-10-29EXTENSION 2 FILED
2020-10-29EXTENSION 2 GRANTED
2020-10-31NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-04-26TEAS EXTENSION RECEIVED
2021-04-26EXTENSION 3 FILED
2021-04-26EXTENSION 3 GRANTED
2021-04-28NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-11-04TEAS EXTENSION RECEIVED
2021-11-04EXTENSION 4 FILED
2021-11-04EXTENSION 4 GRANTED
2021-11-06NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2022-01-18ASSIGNED TO EXAMINER